Profitability
—
Median of the other 4: 3.9%
Return on capital: not in our data yet
return on capital
9.3%5.6%2.1%−37.7%
Mono PharmacareVivanza BiosciencesVenmax Drugs And PharmaceuticalsORTIN GLOBAL
Median of the other 4: 3.9%
BSE: SHYAMACOMP · Healthcare · Pharmaceuticals · Market cap ₹4 Cr
· Prev close ₹3.50 · Volume 300 · 52W ₹2–6
Company profile: not in our data yet
Return on capital: not in our data yet
Median of the other 4: 3.9%
Profit, last 4 quarters vs the 4 before: not in our data yet
P/E not shown: no EPS for four consecutive quarters or a recent year in our data
Generated The other 2 listed peers have a median P/E of 91.5×.
Of profit came in as cash, last 5 fiscal years: not in our data yet
Held by domestic funds: not in our data yet
Generated The 52-week range runs from ₹2.38 to ₹5.55; the 12 Nov close of ₹3.57 sits 38% of the way up.
An earnings call transcript: not in our data yet
Scored statements from the earnings calls: none yet.